FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.
FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.
At Hasselt University (UHasselt), BIOMED is a multidisciplinary institute where fundamental and applied scientific research is conducted in the domain of (biomedical) life sciences. The institute focuses on neurological mechanisms and neuroinflammation, (auto)immunity and cardiological processes. These domains are supported by research programs in bioimaging, biomarkers and rehabilitation.
The Biomedical Research Institute (BIOMED) is one of the research institutes of Hasselt University with a staff of more than 170 researchers, clinicians and technicians. Over the last years, the Biomedical Research Institute (BIOMED) experienced a strong growth in the number of employees, projects, joint ventures and provision of services.
The institute focuses on neurological mechanisms and neuroinflammation, (auto)immunity and cardiological processes. These domains are supported by research programs in bioimaging, biomarkers and rehabilitation.
BIOMED also plays an important role in the development of biomedical life sciences in Limburg. The institute participates in the platform LifeTechLimburg which was set up in 2008 and aims at attracting companies to add value to health care through new technology processes.
The Immunology and Biochemistry Unit of the Biomedical Research Institute (BIOMED) of Hasselt University has a long standing expertise in multiple sclerosis (MS) immunology research. In this context, the MS Network Limburg was set up in 2009 in partnership with the Rehabilitation & MS Centre Overpelt and the rehabilitation study centre REVAL. The aim is advancing MS research to develop better care, treatment and support of MS patients, and jointly start up clinical trials.
Our group is substantially investing in the development of molecular approaches to identify new target antigens for MS and RA using phage display and proteomics. In 2008, two spin-off companies of BIOMED were founded, SEPS Pharma and Apitope, with a focus on prodrug systems and detection assays for autoimmune diseases respectively.
BIOMED also focuses on the communication between the immune system and the nervous system in normal and pathological conditions. Here, our expertise in neuroimmunology, cell physiology, biophysics and neuroanatomy is combined to investigate neurodegeneration: neurodegenerative disorders (MS), brain and spinal cord trauma, excitability disorders (epilepsy) and developmental defects. The basic properties of resident immune cells within the nervous system (microglia) and their influence on brain physiology and development are studied.
BIOMED also has experience in various steady-state and time-resolved (ns) microfluorimetric methods used in biophysics and cell physiology. The instrumentation comprises various fluorescence microscopes, including a confocal laser scanning microscope with spectral detection. In addition, BIOMED offers state-of-the-art patch clamp technology.